2025-02-12 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**0. Executive Summary:**

Intuitive Surgical Inc. (ISRG) is a leading medical device company focused on minimally invasive robotic surgery.  The company exhibits significantly higher cumulative returns compared to the S&P 500 (VOO) over various periods, but recent price action suggests potential short-term volatility.  Strong revenue growth and profitability are observed, although ROE shows some fluctuation.


**1. Performance Comparison & Alpha/Beta Analysis:**

ISRG's cumulative return of 328.81% drastically outperforms VOO's 120.25% return.  The current divergence of 208.6%, placing it at the 93.5th percentile of historical divergence (relative to the min/max range), highlights ISRG's significant outperformance relative to the broader market.

The Alpha/Beta analysis reveals consistently high CAGR (Compound Annual Growth Rate) and high Beta values (suggesting high market sensitivity), especially in recent years. While Alpha is mostly positive, suggesting outperformance beyond market movements, there is some fluctuation. The substantial increase in market capitalization (Cap(B)) reflects the company's growth.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 77.0% | 7.3% | 49.0% | -0.0 | 43.4 |
| 2016-2018  | 89.0% | 8.9% | 71.0% | 0.0 | 56.9 |
| 2017-2019  | 93.0% | 9.8% | 63.0% | 0.5 | 70.3 |
| 2018-2020  | 71.0% | 9.8% | 43.0% | 0.2 | 97.3 |
| 2019-2021  | 113.0% | 9.8% | 42.0% | 0.2 | 128.2 |
| 2020-2022  | 21.0% | 20.6% | 12.0% | 0.2 | 94.6 |
| 2021-2023  | 19.0% | 20.6% | -4.0% | 1.0 | 120.3 |
| 2022-2024  | 128.0% | 20.4% | 95.0% | 1.0 | 186.2 |
| 2023-2025  | 223.0% | 9.9% | 162.0% | 0.8 | 211.0 |


**2. Recent Price Movement:**

* **Closing Price:** $591.65
* **Previous Close:** $595.70
* **5-Day Moving Average:** $589.95
* **20-Day Moving Average:** $584.17
* **60-Day Moving Average:** $553.44

The price is currently below its 5-day and 20-day moving averages, suggesting a potential short-term bearish trend. However, it remains above the 60-day moving average, indicating longer-term support.  The recent price drop of $0.68 is relatively small and doesn't indicate a significant market event.


**3. Technical Indicators & Expected Return:**

* **RSI:** 40.46 (Approaching oversold territory, suggesting potential bounce)
* **PPO:** -0.10 (Negative, indicating bearish momentum)
* **Delta_Previous_Relative_Divergence:** 3.2 (+) (Short-term upward trend in relative strength)
* **Expected Return (2+ years):** 19.9% (Significant outperformance compared to the S&P 500 expected return)


**4. Recent Earnings Analysis:**

The earnings data shows a generally increasing trend in both EPS and revenue, with some minor fluctuations.  Note that there is a duplicate entry for 2024-10-18.

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2024-10-18 | $1.59 | $2.04 B     |
| 2024-07-19 | $1.48 | $2.01 B     |
| 2024-04-19 | $1.54 | $1.89 B     |
| 2023-10-20 | $1.18 | $1.74 B     |
| 2024-10-18 | $1.18 | $1.74 B     | *(Duplicate Entry)*


**5. Financial Information:**

**Revenue and Profitability:**  Revenue shows consistent growth quarter-over-quarter.  Profit margins are high and relatively stable, hovering around 67%.

| Quarter     | Revenue  | Profit Margin |
|-------------|----------|---------------|
| 2024-12-31 | $2.41B   | 68.04%        |
| 2024-09-30 | $2.04B   | 67.41%        |
| 2024-06-30 | $2.01B   | 68.30%        |
| 2024-03-31 | $1.89B   | 65.87%        |
| 2023-12-31 | $1.93B   | 66.24%        |


**Capital and Profitability:** Equity is steadily increasing, but ROE (Return on Equity) fluctuates, indicating varying efficiency in using shareholder equity to generate profits.

| Quarter     | Equity   | ROE   |
|-------------|----------|-------|
| 2024-12-31 | $16.43B  | 4.17% |
| 2024-09-30 | $15.58B  | 3.63% |
| 2024-06-30 | $14.71B  | 3.58% |
| 2024-03-31 | $13.96B  | 3.90% |
| 2023-12-31 | $13.31B  | 4.56% |



**6. Overall Analysis:**

ISRG demonstrates strong historical performance significantly exceeding the S&P 500.  Revenue and profitability are robust. However, recent price action suggests some short-term weakness.  The high beta indicates sensitivity to broader market movements.  While the expected long-term return is positive, investors should monitor short-term price volatility and consider the inherent risk associated with a high-growth, high-beta stock.  Further investigation into the reasons for the recent price decline and the fluctuations in ROE would be beneficial.  The duplicate entry in the earnings data requires clarification.
